Quantcast
Last updated on May 28, 2012 at 21:34 EDT

Phase Forward to Present at the Pacific Crest 3rd Annual On-Demand Conference

February 20, 2008
Repost This

Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its chief financial officer, Rodger Weismann, will present at the Pacific Crest 3rd Annual On-Demand Conference at The Fairmont Hotel in San Francisco, California.

The Phase Forward presentation is scheduled for Thursday, February 28, 2008 at 2:30 p.m. Pacific Time (5:30 p.m. Eastern Time). The presentation will be webcast live and will be available by visiting the Investors section of the company’s website at www.phaseforward.com. The webcast will be archived on the company’s website for 30 days after the conference ends.

About Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm™), phase I clinic automation (LabPas™), clinical data management (Clintrial™), clinical trials signal detection (CTSD™), strategic pharmacovigilance (WebVDME™ and Signal Management), adverse event reporting (Clintrace™) and applied data standards (WebSDM™). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward’s products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 260 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, or FDA, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec, and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.